Outcome of neoadjuvant-treated young patients with hormone receptor-positive breast cancer.

被引：0
|
作者：
Mayte Villarreal-Garza, Cynthia
Arce-Salinas, Claudia
Lasa, Federico
Reynoso, Nancy
Antonio Matus, Juan
Lara-Medina, Fernando
Bargallo-Rocha, Enrique
Flores Diaz, Diana Fabiola
Shaw, Robin J.
Alvarado-Miranda, Alberto
Jaime Castaneda, Noel
Alejandra Martinez-Cannon, Bertha
Mohar, Alejandro
机构：
[1] Inst Nacl Cancerol, Mexico City, DF, Mexico
[2] Tecnol Monterrey, San Pedro Garza Garcia, Mexico
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e11577
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11577
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant use of hormonal therapy in elderly patients with early or locally advanced hormone receptor-positive breast cancer
    Macaskill, E. Jane
    Renshaw, Lorna
    Dixon, J. Michael
    [J]. ONCOLOGIST, 2006, 11 (10): : 1081 - 1088
  • [42] Neoadjuvant stereotactic body radiotherapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer.
    Niu, Nan
    Cao, Shuo
    Chen, Guanglei
    Xue, Jinqi
    Zhang, Yu
    Xu, Yongqing
    Yin, Jianqiao
    Liu, Chao
    Jiang, Xiaofan
    Tang, Meiyue
    Xu, Qianshi
    Jia, Mingxuan
    Zhang, Xu
    Zhang, Zhenyong
    Li, Huajun
    Li, Ailin
    Liu, Caigang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] A mathematical model to predict for response to neoadjuvant hormone therapy in elderly patients with hormone receptor (HR)-positive breast cancer.
    Zoubir, M.
    Bouaziz, J.
    Rouzier, R.
    Garbay, J. R.
    Spielmann, M.
    Conforti, R.
    Bongain, A.
    Mathieu, M. C.
    Vielh, P.
    Bourgier, C.
    Lallement, M.
    Andre, F.
    Delaloge, S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S54 - S54
  • [44] The Natural History of Hormone Receptor-Positive Breast Cancer
    Lim, Elgene
    Metzger-Filho, Otto
    Winer, Eric P.
    [J]. ONCOLOGY-NEW YORK, 2012, 26 (08): : 688 - +
  • [45] Postmenopausal Hormone Receptor-Positive Advanced Breast Cancer
    Connolly, Roisin M.
    Stearns, Vered
    [J]. ONCOLOGY-NEW YORK, 2013, 27 (06): : 571 - +
  • [46] Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer
    Turner, Nicholas C.
    Oliveira, Mafalda
    Howell, Sacha J.
    Dalenc, Florence
    Cortes, Javier
    Moreno, Henry L. Gomez
    Hu, Xichun
    Jhaveri, Komal
    Krivorotko, Petr
    Loibl, Sibylle
    Morales Murillo, Serafin
    Okera, Meena
    Park, Yeon Hee
    Sohn, Joohyuk
    Toi, Masakazu
    Tokunaga, Eriko
    Yousef, Samih
    Zhukova, Lyudmila
    de Bruin, Elza C.
    Grinsted, Lynda
    Schiavon, Gaia
    Foxley, Andrew
    Rugo, Hope S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (22): : 2058 - 2070
  • [47] Everolimus in the treatment of hormone receptor-positive breast cancer
    Chavez-MacGregor, Mariana
    Gonzalez-Angulo, Ana Maria
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (12) : 1835 - 1843
  • [48] Rat Models of Hormone Receptor-Positive Breast Cancer
    Nicotra, Raquel
    Lutz, Catrin
    Messal, Hendrik A.
    Jonkers, Jos
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2024, 29 (01)
  • [49] Precision Medicine in Hormone Receptor-Positive Breast Cancer
    Nasrazadani, Azadeh
    Thomas, Roby A.
    Oesterreich, Steffi
    Lee, Adrian V.
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [50] EVEROLIMUS TREATMENT FOR HORMONE RECEPTOR-POSITIVE BREAST CANCER
    不详
    [J]. CANCER DISCOVERY, 2012, 2 (01) : 12 - 12
12345